Home | Business News | Browse by Publication | B | Business Wire

Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile.

Publication: Business Wire
Publication Date: 27-JUL-09 		Format: Online
Delivery: Immediate Online Access

Article Excerpt
NEW YORK -- Reportlinker.com announces that a new market research report is available in its catalogue.

Reportlinker Adds Bayer Schering Pharma AG: PharmaVitae Profile

http://www.reportlinker.com/p0133014/Reportlinker-Adds-Bayer-Schering-Pharma-AG-PharmaVitae-Profile.html

Introduction

This analysis examines the historical and forecast performance for Bayer Schering in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information

Reasons to Purchase

*Benchmark Bayer Schering Pharma's performance against key rivals in the ethical pharmaceutical sector

*Analyse how Bayer's acquisition of Schering AG in 2006 has notably enhanced the company's HealthCare division

*Assess how an increased healthcare focus and merger-related synergies will drive an increase in operating profit at an 8.4% CAGR over 200814

ABOUT DATAMONITOR HEALTHCARE 2

About the PharmaVitae team 2

Chapter 1 About this profile 3

PharmaVitae Explorer database 3

Chapter structure 3

Executive summary 3

Quarterly news update 3

Company introduction 3

Company sales 4

Company financials 4

Key products and competitors 4

Data sourcing 4

Sales data 4

Analyst consensus 4

Chapter 2 Executive summary 5

Key findings 5

Prescription pharmaceutical sales and growth rate performance, 2002-14 6

Financial performance, 2002-14 7

Bayer: PharmaVitae forecasts at a glance 8

Strategic insight 9

Bayer's diversified structure is unusual within Big Pharma peer set 9

Weak revenue performance over 2001-03 initiates restructuring strategy 10

Bayer's restructuring efforts have proved successful 11

Bayer's portfolio to drive prescription pharma growth over 2008-14 13

SWOT analysis 14

Strengths 14

Weaknesses 15

Opportunities 16

Threats 17

Table of Contents 19

Table of figures 21

Chapter 3 Quarterly news update 22

Product...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from Business Wire
Research and Markets: Transdermal Drug Delivery: Patches, Gels, Active..., July 27, 2009
Reportlinker Adds Key NAND Flash Memory Design Intellectual Property., July 27, 2009
Research and Markets: This Essential Report on ATMs, Cash Dispensing a..., July 27, 2009
Reportlinker Adds Research Report on China's Dairy Cattle Market.(Repo..., July 27, 2009
Research and Markets: Financial Outlook Prompts Review of IP Telephony..., July 27, 2009

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.